First Identification of the New Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant (B.1.1.529) in Italy | Zendy

Valeria Micheli | Zendy; Fiorenza Bracchitta | Zendy; Alberto Rizzo | Zendy; Alessandro Mancon | Zendy; Davide Mileto | Zendy; Alessandra Lombardi | Zendy; Paola Stefanelli | Zendy; Maria Rita Gismondo | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

First Identification of the New Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant (B.1.1.529) in Italy

Author(s) -

Valeria Micheli,

Fiorenza Bracchitta,

Alberto Rizzo,

Alessandro Mancon,

Davide Mileto,

Alessandra Lombardi,

Paola Stefanelli,

Maria Rita Gismondo

Publication year - 2021

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciab1044

Subject(s) - medicine , covid-19 , coronavirus , vaccination , virology , respiratory system , mutation , identification (biology) , betacoronavirus , genome , immunology , gene , genetics , disease , biology , outbreak , infectious disease (medical specialty) , botany

We identified the first case in Italy of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.529 variant, using whole-genome sequencing in an Italian subject traveling from Mozambique. Specific mutation profiles deserve further investigations to clarify potential effects on vaccination efficacy. This case highlights the crucial role of rapid and continuous surveillance of SARS-CoV-2 variant circulation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research